Matthew Cohen
Patrimonio netto: 968 502 $ in data 30/06/2026
Patrimonio netto: 968 502 $ in data 30/06/2026
Matthew G.
Cohen is currently the Managing Director at VV Manager LLC since 2025 and Director at Arrowhead Pharmaceuticals, Inc. since 2026.
Formerly, Dr. Cohen was a Portfolio Manager at JPMorgan Investment Management, Inc. from 2005 to 2025 and a Healthcare Analyst at Narragansett Asset Management LLC in 2003.
Education includes graduate studies at McGill University and an MBA from New York University, conferred in 2001.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2026 | 11.882 ( 0,01% ) | 968 502 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/06/2026 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Investitore di Private Equity | 02/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Analyst-Equity | 11/02/2025 |
Narragansett Asset Management LLC
Narragansett Asset Management LLC Investment ManagersFinance Narragansett Asset Management employs a fundamental value-added research approach and adheres to a long-term investment horizon. The firm invests in equities, debt, commodities and currencies, depending on the current investment climate. | Presidente | 27/02/2003 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Finance |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Narragansett Asset Management LLC
Narragansett Asset Management LLC Investment ManagersFinance Narragansett Asset Management employs a fundamental value-added research approach and adheres to a long-term investment horizon. The firm invests in equities, debt, commodities and currencies, depending on the current investment climate. | Finance |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale